Infection and coronary heart diseaseELLIS, R. W.Journal of medical microbiology. 1997, Vol 46, Num 7, pp 535-539, issn 0022-2615Article

The applications of synthetic oligonucleotides to molecular biologyELLIS, R. W.Pharmaceutical research. 1986, Vol 3, Num 4, pp 195-207, issn 0724-8741Article

Development of combination vaccinesELLIS, R. W.Vaccine. 1999, Vol 17, Num 13-14, pp 1635-1642, issn 0264-410XConference Paper

Variation and range of mercury uptake into plants at a mercury-contaminated abandoned mine siteELLIS, R. W; ESLICK, L.Bulletin of environmental contamination and toxicology. 1997, Vol 59, Num 5, pp 763-769, issn 0007-4861Article

New technologies for making vaccinesELLIS, R. W.Vaccine. 1999, Vol 17, Num 13-14, pp 1596-1604, issn 0264-410XConference Paper

Strategic challenges in designing and producing modern biotechnology vaccines and transferring technologyELLIS, R. W.Developments in biologicals. 2002, Vol 110, pp 3-11, issn 1424-6074, 9 p.Conference Paper

The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infantsCLARK, H. F; OFFIT, P. A; PLOTKIN, S. A et al.The Journal of infectious diseases. 1996, Vol 174, pp S73-S80, issn 0022-1899, SUP1Conference Paper

In vitro T cell immune responses to the PreS2 antigen of the hepatitis B virus envelope protein in PreS2+S vaccine recipients : absence of cross-reactivity of subtypes at a major T cell recognition siteCUPPS, T. R; TIBBLES, J; HURNI, W. M et al.The Journal of immunology (1950). 1993, Vol 151, Num 6, pp 3353-3360, issn 0022-1767Article

An enzyme-linked immunosorbent assay for quantitation of Haemophilus influzenzae type b polysaccharide-specific IgG1 and IgG2 in human and infant rhesus monkey seraDOLAN, K. T; STAUB, J. M; SCHOFIELD, T. L et al.Journal of immunoassay. 1991, Vol 12, Num 4, pp 543-564, issn 0197-1522Article

Varicella vaccine (VARIVAX) in healthy children and adolescents : results from clinical trials, 1987 to 1989JO WHITE, C; KUTER, B. J; HILDEBRAND, C. S et al.Pediatrics (Evanston). 1991, Vol 87, Num 5, pp 604-610, issn 0031-4005Article

Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB) : clinical evaluationAHONKHAI, V. I; LUKACS, L. J; GERETY, R. J et al.Pediatrics (Evanston). 1990, Vol 85, Num 4, pp 676-681, issn 0031-4005, 2Article

Identification and sequence of the gene encoding gpIII, a major glycoprotein of varicella-zoster virusKELLER, P. M; DAVISON, A. J; LOWE, R. S et al.Virology (New York, NY). 1987, Vol 157, Num 2, pp 526-533, issn 0042-6822Article

Varicella-zoster virus as a live vector for the expression of foreign genesLOWE, R. S; KELLER, P. M; KEECH, B. J et al.Proceedings of the National Academy of Sciences of the United States of America. 1987, Vol 84, Num 11, pp 3896-3900, issn 0027-8424Article

Purification of individual varicella-zoster virus (VZV) glycoproteins gpI, gpII, and gpIII and their use in ELISA for detection of VZV glycoprotein-specific antibodiesKELLER, P. M; LONERGAN, K; NEFF, B. J et al.Journal of virological methods. 1986, Vol 14, Num 2, pp 177-188, issn 0166-0934Article

Neurologically presenting Whipple disease : case report and review of the literatureBUCKLE, M. J; ELLIS, R. W; BONE, M et al.Journal of clinical pathology. 2008, Vol 61, Num 10, pp 1140-1141, issn 0021-9746, 2 p.Article

Influenza vaccine technologies and the use of the cell-culture process (cell-culture influenza vaccine)MABROUK, T; ELLIS, R. W.Developments in biologicals. 2002, Vol 110, pp 125-134, issn 1424-6074, 10 p.Conference Paper

Reduction of the bioavailability of 20 μg/kg aflatoxin in trout feed containing clayELLIS, R. W; CLEMENTS, M; TIBBETTS, A et al.Aquaculture (Amsterdam). 2000, Vol 183, Num 1-2, pp 179-188, issn 0044-8486Article

Protection against papillomavirus with a polynucleotide vaccineDONNELLY, J. J; MARTINEZ, D; JANSEN, K. U et al.The Journal of infectious diseases. 1996, Vol 173, Num 2, pp 314-320, issn 0022-1899Article

Muon spin relaxation in the heavy fermion system UPt₃LUKE, G. M; LE, L. P; ELLIS, R. W et al.Journal of applied physics. 1991, Vol 70, Num 10, pp 5788-5790, issn 0021-8979, 2Conference Paper

Immunogenicity of a new Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) (PedvaxHIB)VELLA, P. P; STAUB, J. M; TOLMAN, R. L et al.Pediatrics (Evanston). 1990, Vol 85, Num 4, pp 668-675, issn 0031-4005, 2Article

Vero cell-expressed Epstein-Barr virus (EBV) gp350/220 protects marmosets from EBV challengeEMINI, E. A; SCHLEIF, W. A; SILBERKLANG, M et al.Journal of medical virology. 1989, Vol 27, Num 2, pp 120-123, issn 0146-6615Article

Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune responseBRUNELL, P. A; NOVELLI, V. M; KELLER, P. M et al.The Journal of infectious diseases. 1987, Vol 156, Num 3, pp 430-435, issn 0022-1899Article

Regulated overproduction of the GAL 4 gene product greatly increases expression from galactose-inducible promoters on multi-copy expression vectors in yeastSCHULTZ, L. D; HOFMANN, K. J; MYLIN, L. M et al.Gene (Amsterdam). 1987, Vol 61, Num 2, pp 123-133, issn 0378-1119Article

Remarks on the mechanism of ethylene formation from methyl alcoholOLAH, G. A; SURYA PRAKASH, G. K; ELLIS, R. W et al.Journal of the Chemical Society. Chemical communications. 1986, Num 1, pp 9-10, issn 0022-4936Article

Identification and structure of the gene encoding gpII, a major glycoprotein of varicella-zoster virusKELLER, P. M; DAVISON, A. J; LOWE, R. S et al.Virology (New York, NY). 1986, Vol 152, Num 1, pp 181-191, issn 0042-6822Article